Veterinary Medicine Information website

Nobilis E.coli inac emulsion for injection for chickens

Authorised
  • Escherichia coli, fimbrial adhesin F11
  • Escherichia coli, flagellar toxin

Product identification

Medicine name:
Nobilis E.coli inac emulsion for injection for chickens
Active substance:
  • Escherichia coli, fimbrial adhesin F11
  • Escherichia coli, flagellar toxin
Target species:
  • Chicken
Route of administration:
  • Intramuscular use
  • Subcutaneous use

Product details

Active substance and strength:
  • Escherichia coli, fimbrial adhesin F11
    100.00
    microgram(s)
    /
    0.50
    millilitre(s)
  • Escherichia coli, flagellar toxin
    100.00
    microgram(s)
    /
    0.50
    millilitre(s)
Pharmaceutical form:
  • Emulsion for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Chicken
      • Meat and offal
        35
        day
      • Egg
        no withdrawal period
  • Subcutaneous use
    • Chicken
      • Meat and offal
        35
        day
      • Egg
        no withdrawal period
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI01AB05
Authorisation status:
  • Valid
Authorised in:
  • Ireland
Available in:
  • Ireland
Package description:
  • 250 ml (500 doses) in one glass type II vial closed with a nitryl rubber stopper and sealed with a coded aluminium cap in a cardboard box.
  • 500 ml (1000 doses) in one glass type II vial closed with a nitryl rubber stopper and sealed with a coded aluminium cap in a cardboard box.
  • 500 ml (1000 doses) in one PET vial closed with a nitryl rubber stopper and sealed with a coded aluminium cap in a cardboard box.
  • 250 ml (500 doses) in one PET vial closed with a nitryl rubber stopper and sealed with a coded aluminium cap in a cardboard box.

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Intervet (Ireland) Limited
Marketing authorisation date:
Manufacturing sites for batch release:
  • Intervet International B.V.
Responsible authority:
  • Health Products Regulatory Authority
Authorisation number:
  • VPA10996/083/001
Date of authorisation status change:
Reference member state:
  • Netherlands
Procedure number:
  • NL/V/0017/001
Concerned member states:
  • Austria
  • Belgium
  • France
  • Germany
  • Greece
  • Ireland
  • Italy
  • Portugal
  • Spain
  • United Kingdom (Northern Ireland)